188 related articles for article (PubMed ID: 18656981)
1. Synthesis of heterocyclic analogues of epibatidine via 7-azabicyclo[2.2.1]hept-2-yl radical intermediates. 1. Intermolecular reactions.
Gómez-Sánchez E; Soriano E; Marco-Contelles J
J Org Chem; 2008 Sep; 73(17):6784-92. PubMed ID: 18656981
[TBL] [Abstract][Full Text] [Related]
2. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
Malpass JR; White R
J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
[TBL] [Abstract][Full Text] [Related]
3. Aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes: syntheses of (+/-)-epibatidine and (+/-)-epiboxidine.
Armstrong A; Bhonoah Y; Shanahan SE
J Org Chem; 2007 Oct; 72(21):8019-24. PubMed ID: 17867705
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 7-azabicyclo[2.2.1]heptane and 2-oxa-4-azabicyclo[3.3.1]non-3-ene derivatives by base-promoted heterocyclization of alkyl N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)carbamates and N-(cis(trans)-3,trans(cis)-4-dibromocyclohex-1-yl)-2,2,2-trifluoroacetamides.
Gómez-Sanchez E; Soriano E; Marco-Contelles J
J Org Chem; 2007 Nov; 72(23):8656-70. PubMed ID: 17927252
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
Carroll FI; Liang F; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2001 Jun; 44(13):2229-37. PubMed ID: 11405659
[TBL] [Abstract][Full Text] [Related]
7. exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
Che D; Wegge T; Stubbs MT; Seitz G; Meier H; Methfessel C
J Med Chem; 2001 Jan; 44(1):47-57. PubMed ID: 11141087
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic analysis of intramolecular free radical reactions toward synthesis of 7-azabicyclo[2.2.1]heptane derivatives.
Soriano E; Marco-Contelles J
J Org Chem; 2009 Jun; 74(11):4061-7. PubMed ID: 19402620
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
Cheng J; Zhang C; Stevens ED; Izenwasser S; Wade D; Chen S; Paul D; Trudell ML
J Med Chem; 2002 Jul; 45(14):3041-7. PubMed ID: 12086489
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine.
Carroll FI; Robinson TP; Brieaddy LE; Atkinson RN; Mascarella SW; Damaj MI; Martin BR; Navarro HA
J Med Chem; 2007 Dec; 50(25):6383-91. PubMed ID: 17994682
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues.
Carroll FI; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
J Med Chem; 2005 Nov; 48(23):7491-5. PubMed ID: 16279810
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of bridgehead-substituted azabicyclo[2.2.1]heptane and -[3.3.1]nonane derivatives for the elaboration of α7 nicotinic ligands.
Slowinski F; Ben Ayad O; Vache J; Saady M; Leclerc O; Lochead A
J Org Chem; 2011 Oct; 76(20):8336-46. PubMed ID: 21923123
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and electrophysiological studies of a novel epibatidine analogue.
Spang JE; Patt JT; Bertrand S; Bertrand D; Westera G; Schubiger PA
J Recept Signal Transduct Res; 1999; 19(1-4):521-31. PubMed ID: 10071782
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of enantiomerically pure 1,2-diamine derivatives of 7-azabicyclo[2.2.1]heptane. New leads as glycosidase inhibitors and rigid scaffolds for the preparation of peptide analogues.
Moreno-Vargas AJ; Schütz C; Scopelliti R; Vogel P
J Org Chem; 2003 Jul; 68(14):5632-40. PubMed ID: 12839456
[TBL] [Abstract][Full Text] [Related]
15. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
Huang Y; Zhu Z; Xiao Y; Laruelle M
Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.
Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA
Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.
Carroll FI; Lee JR; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR
J Med Chem; 2001 Nov; 44(24):4039-41. PubMed ID: 11708907
[TBL] [Abstract][Full Text] [Related]
18. Epibatidine structure-activity relationships.
Carroll FI
Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD
J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging.
Dolci L; Dolle F; Valette H; Vaufrey F; Fuseau C; Bottlaender M; Crouzel C
Bioorg Med Chem; 1999 Mar; 7(3):467-79. PubMed ID: 10220033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
